A current overview of the biological and cellular effects of nanosilver

SJ Cameron, F Hosseinian, WG Willmore - International journal of …, 2018 - mdpi.com
Nanosilver plays an important role in nanoscience and nanotechnology, and is becoming
increasingly used for applications in nanomedicine. Nanosilver ranges from 1 to 100 …

Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials

D Huang, W Liao, J Li, T Chen, X Wang… - Advanced Functional …, 2024 - Wiley Online Library
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disease that
constitutes the third most common cause of death among elderly individuals. AD patients …

Breaking barriers in alzheimer's disease: the role of advanced drug delivery systems

D Shekho, R Mishra, R Kamal, R Bhatia, A Awasthi - AAPS PharmSciTech, 2024 - Springer
Abstract Alzheimer's disease (AD), characterized by cognitive impairment, brain plaques,
and tangles, is a global health concern affecting millions. It involves the build-up of amyloid …

[HTML][HTML] Nanoneurotoxicity and potential nanotheranostics for Alzheimer's disease

CE Carro, AR Pilozzi, X Huang - EC pharmacology and toxicology, 2019 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of senile dementia and it is characterized
by cognitive, motor and memory impairments. AD neuropathology includes toxic biomarkers …

Effects of eugenol on alzheimer's disease-like manifestations in insulin-and Aβ-induced rat models

P Taheri, P Yaghmaei, HS Tehrani, A Ebrahim-Habibi - Neurophysiology, 2019 - Springer
Eugenol is a phenylpropene having antidepressant properties. We investigated the effect of
eugenol on amyloid plaques as a hallmark of Alzheimer's disease (AD) in two AD rat …

Nanotheranostic agents for neurodegenerative diseases

P Padmanabhan, M Palanivel, A Kumar… - Emerging Topics in …, 2020 - portlandpress.com
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's
disease (PD), affect the ageing population worldwide and while severely impairing the …

Neuroprotective effect of Bis (Indolyl) phenylmethane in Alzheimer's disease rat model through inhibition of hen Lysozyme amyloid fibril-induced neurotoxicity

H Fazelinejad, E Zahedi, S Nazarian… - Journal of the Iranian …, 2023 - Springer
Amyloid aggregates are the hallmarks of several disorders, including Huntington's,
Parkinson's and Alzheimer's diseases. Compounds that could inhibit amyloid fibril formation …

Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights …

H Fazelinejad, E Zahedi, M Khadivi - Neuroscience Letters, 2024 - Elsevier
Alzheimer's disease (AD) is a prevalent form of dementia in the elderly. There is currently no
effective treatment available for this disease. Diagnosis of AD typically relies on clinical …

Dual function of Selenium nanoparticles: Inhibition or induction of lysozyme amyloid aggregation and evaluation of their cell-based cytotoxicity.

H Ramshini, S Rostami - Archives Italiennes de Biologie, 2021 - search.ebscohost.com
Aberrant protein aggregation and the formation of amyloid deposits are associated with
numerous neuro-and non-neurodegenerative disorders. Thus, one potential strategy is to …

Silver nanoparticles synthesized using Tualang honey ameliorate seizures, locomotor activity, and memory function in KA-induced status epilepticus in male rats

H Hasim, SKNM Salam, PV Rao… - Biomedical Research …, 2022 - biomedpress.org
Introduction: In recent years, green synthesis of silver nanoparticles using natural products
has been increasingly utilized in the biomedical field as a therapeutic approach for …